With the opening of its state-of-the-art facility in Rockville in 2017, GSK has been strengthening its manufacturing presence in the US. As a result, the site’s portfolio of programs and bulk production has been growing steadily, with
Philadelphia’s soaring life sciences commercial real estate market is being driven by the combination of strong demand for advanced lab and manufacturing facilities and near record low vacancy rates.
Virginia Beach is seeking to build a bio cluster in the heart of everything Virginia Beach has to offer. The cluster reached an important milestone, recently opening a brand new accelerator lab constructed and managed by BioHealth Capital Region (BHCR) stalwart Facility Logix. VABeachBio and its partners see this new lab as a sign of great things to come.
Its Women’s History Month and being on the heels of Black History Month, BioBuzz is highlighting three successful black women in industry to straddle the importance of both.
Philadelphia, the birthplace of cell and gene therapy, is home to a number of companies focused on developing multiple treatment options for rare diseases, those that affect less than 200,000 people in the United States.
Vigene, a gene therapy development company, said it intends to lease a 52,000 square-foot manufacturing space at 14200 Shady Grove Road that will nearly double the company’s existing manufacturing footprint. The new space is in addition to its existing headquarters, R&D, and manufacturing locations that opened in Rockville last year. The additional space from the new facility will allow the company to expand its current headcount of 125 by the addition of 245 more employees.
Covid 19 Timeline Year 2020 *click article titles below to read original BioBuzz content from the past year MARCH 4/7/2020 Coronavirus Pandemic Good News Roundup Sheds Light Amidst Trying COVID-19 [….]
Sanaria Receives Substantial Investment from EU Malaria Fund
The coronavirus pandemic has had profound negative impacts on large swaths of the U.S. economy. However, certain sectors like the life sciences have remained steady or have even grown, as many of these companies have pivoted to producing COVID-19-related tests, materials, therapeutics, and vaccines.
Well to say that the first two quarters of 2020 have been eventful in the life science sector is the understatement of the century. The BioBuzz team has been there for every twist and turn as the coronavirus pandemic reshaped everyday life and galvanized the BioHealth Capital Region (BHCR) to rise up and fight COVID-19.